Prostate Cancer Pathophysiology and Clinical Manifestations
14 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the predominant type of prostate cancer found in patients?

  • Androgen-dependent adenocarcinoma (correct)
  • Small cell carcinoma
  • Squamous cell carcinoma
  • Urothelial carcinoma
  • Which symptom is least likely associated with advanced prostate cancer?

  • Weight gain (correct)
  • Bone pain
  • Urinary frequency
  • Dysuria
  • What is the most common site of metastasis for prostate cancer?

  • Liver
  • Lungs
  • Bone (correct)
  • Brain
  • What is the major androgen responsible for prostate cell proliferation?

    <p>Testosterone</p> Signup and view all the answers

    Which management option is commonly part of the approach to treating localized prostate cancer?

    <p>Total prostatectomy</p> Signup and view all the answers

    What demographic has the highest risk for developing prostate cancer?

    <p>Men with a family history of the disease</p> Signup and view all the answers

    Which statement about the PSA antigen test is correct?

    <p>PSA can be elevated in other prostate conditions.</p> Signup and view all the answers

    What percentage of prostate cancers are typically diagnosed in men over the age of 65?

    <p>75%</p> Signup and view all the answers

    Which of the following statements about the PSA antigen test is true?

    <p>Elevated levels can occur in conditions other than cancer.</p> Signup and view all the answers

    What is the primary clinical presentation of prostate cancer until it is advanced?

    <p>Asymptomatic</p> Signup and view all the answers

    Which of the following is NOT considered a risk factor for developing prostate cancer?

    <p>Caucasian ethnicity</p> Signup and view all the answers

    What management option is least likely to be considered for prostate cancer staging?

    <p>Chemotherapy</p> Signup and view all the answers

    What is the most common site of metastasis for prostate cancer?

    <p>Bone</p> Signup and view all the answers

    Which statement about the progression of symptoms in prostate cancer is true?

    <p>Symptoms progressively worsen over time.</p> Signup and view all the answers

    Study Notes

    Pathophysiology

    • Prostate cancer primarily manifests as androgen-dependent adenocarcinoma, accounting for 95% of cases.
    • Tumors typically develop in the peripheral zone of the prostate rather than near the urethra.
    • Androgens interact with androgen receptors in prostate cells, promoting cell proliferation.
    • Testosterone serves as the principal androgen contributing to prostate health.

    Clinical Manifestations

    • Early stages often show no symptoms, becoming apparent only as the disease advances.
    • Patients may experience bladder outlet obstruction, leading to urinary issues such as dysuria and increased frequency.
    • Progression of symptoms can result in ureteral or rectal obstruction, intensifying discomfort.

    Metastasis

    • Prostate cancer can spread to various body sites; however, bone metastases are the most prevalent, causing significant bone pain.

    Management

    • Prostate-specific antigen (PSA) testing is used for evaluation, despite its low sensitivity.
    • While PSA is specific to the prostate, it lacks specificity for cancer, as levels can rise due to benign prostatic hyperplasia (BPH) or prostatitis.
    • Biopsy procedures are necessary for accurate staging of the cancer.
    • Treatment decisions depend on the cancer stage and may include:
      • Active surveillance (do nothing).
      • Total prostatectomy (surgical removal of the prostate).
      • Transurethral resection of the prostate (TURP).
      • Radiation therapy.
      • Chemotherapy.
      • Hormonal therapy.

    Epidemiology

    • Prostate cancer is the most common cancer in men, excluding skin cancers.
    • The lifetime risk of developing prostate cancer is approximately 15.9%.
    • A significant 75% of cases are diagnosed in men aged over 65 years.
    • It ranks as the sixth leading cause of cancer-related death globally.

    Risk Factors

    • Increased risk associated with family history of prostate cancer.
    • Age is a critical factor, with higher incidence in older adults.
    • Black or African American descent is linked to elevated risk.
    • The impact of dietary factors on prostate cancer risk remains ambiguous.

    Pathophysiology

    • Prostate cancer primarily manifests as androgen-dependent adenocarcinoma, accounting for 95% of cases.
    • Tumors typically develop in the peripheral zone of the prostate rather than near the urethra.
    • Androgens interact with androgen receptors in prostate cells, promoting cell proliferation.
    • Testosterone serves as the principal androgen contributing to prostate health.

    Clinical Manifestations

    • Early stages often show no symptoms, becoming apparent only as the disease advances.
    • Patients may experience bladder outlet obstruction, leading to urinary issues such as dysuria and increased frequency.
    • Progression of symptoms can result in ureteral or rectal obstruction, intensifying discomfort.

    Metastasis

    • Prostate cancer can spread to various body sites; however, bone metastases are the most prevalent, causing significant bone pain.

    Management

    • Prostate-specific antigen (PSA) testing is used for evaluation, despite its low sensitivity.
    • While PSA is specific to the prostate, it lacks specificity for cancer, as levels can rise due to benign prostatic hyperplasia (BPH) or prostatitis.
    • Biopsy procedures are necessary for accurate staging of the cancer.
    • Treatment decisions depend on the cancer stage and may include:
      • Active surveillance (do nothing).
      • Total prostatectomy (surgical removal of the prostate).
      • Transurethral resection of the prostate (TURP).
      • Radiation therapy.
      • Chemotherapy.
      • Hormonal therapy.

    Epidemiology

    • Prostate cancer is the most common cancer in men, excluding skin cancers.
    • The lifetime risk of developing prostate cancer is approximately 15.9%.
    • A significant 75% of cases are diagnosed in men aged over 65 years.
    • It ranks as the sixth leading cause of cancer-related death globally.

    Risk Factors

    • Increased risk associated with family history of prostate cancer.
    • Age is a critical factor, with higher incidence in older adults.
    • Black or African American descent is linked to elevated risk.
    • The impact of dietary factors on prostate cancer risk remains ambiguous.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    Learn about the pathophysiology and clinical manifestations of prostate cancer, including the role of androgens and symptoms of bladder outlet obstruction. This quiz covers the basics of prostate cancer and its effects on the body.

    More Like This

    Use Quizgecko on...
    Browser
    Browser